GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » Sale Of Business

Kilitch Drugs (India) (BOM:524500) Sale Of Business : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) Sale Of Business?

Kilitch Drugs (India)'s sale of business for the three months ended in Dec. 2024 was ₹0 Mil. It means Kilitch Drugs (India) gained ₹0 Mil from selling business. Kilitch Drugs (India)'s sale of business for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Sep. 2024 ), Kilitch Drugs (India) gained the same money from selling business in Dec. 2024 (₹0 Mil).


Kilitch Drugs (India) Sale Of Business Historical Data

The historical data trend for Kilitch Drugs (India)'s Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Sale Of Business Chart

Kilitch Drugs (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kilitch Drugs (India) Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kilitch Drugs (India) Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kilitch Drugs (India) Sale Of Business Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines